| Literature DB >> 2909291 |
N J Petrelli1, P J Creaven, L Herrera, A Mittelman.
Abstract
Following the observation of antitumor activity for the combination of 5-fluorouracil (5-FU) and cisplatin in metastatic colorectal carcinoma, the combination of 5-FU and iproplatin was tested, also in colorectal carcinoma, in the hope of attaining equivalent activity without the nephrotoxicity observed with 5-FU/cisplatin. However, no responses were achieved with 5-FU/iproplatin.Entities:
Mesh：
Substances：
Year: 1989 PMID： 2909291 DOI： 10.1007/BF00258461
Source DB: PubMed Journal: Cancer Chemother Pharmacol ISSN： 0344-5704 Impact factor: 3.333